The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genome-wide burden survival tests for patients with metastatic prostate cancer on androgen receptor-targeted therapies in the Million Veterans Program dataset.
 
Danielle Candelieri-Surette
No Relationships to Disclose
 
Dan Berlowitz
No Relationships to Disclose
 
Tyler Nelson
No Relationships to Disclose
 
Hannah Carter
No Relationships to Disclose
 
Brent Rose
Employment - UC San Diego Health
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Jason Vassy
No Relationships to Disclose
 
Richard Hauger
No Relationships to Disclose
 
Julie Lynch
Research Funding - AstraZeneca (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst)
 
Craig Teerlink
Research Funding - Alnylam (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Biodesix (Inst); Celgene (Inst); Cerner Enviza, (Inst); GlaxoSmithKline (Inst); IQVIA Inc (Inst); Janssen (Inst); Novartis (Inst); PAREXEL (Inst)